 | QP1 | Name: | N-{3-[(4-{4-(4-fluorophenyl)-2-[(2-methoxyethyl)sulfanyl]-1H-imidazol-5-yl}pyridin-2-yl)amino]-4-methoxyphenyl}propanamide | Formula: | C27 H28 F N5 O3 S | SMILES: | c1c(ccc(c1)F)c4c(c3cc(Nc2cc(ccc2OC)NC(CC)=O)ncc3)nc(SCCOC)n4 | InChi: | InChI=1S/C27H28FN5O3S/c1-4-24(34)30-20-9-10-22(36-3)21(16-20)31-23-15-18(11-12-29-23)26-25(17-5-7-19(28)8-6-17)32-27(33-26)37-14-13-35-2/h5-12,15-16H,4,13-14H2,1-3H3,(H,29,31)(H,30,34)(H,32,33) | Definition date: | 2019-12-05 | Last modified: | 2024-09-27 | Release date: | 2020-04-22 | Identifier: | N-{3-[(4-{4-(4-fluorophenyl)-2-[(2-methoxyethyl)sulfanyl]-1H-imidazol-5-yl}pyridin-2-yl)amino]-4-methoxyphenyl}propanamide |
|
 | XZK | Name: | N-(4-carbamoylphenyl)-2-chloro-5-nitrobenzamide | Formula: | C14 H10 Cl N3 O4 | SMILES: | O=C(Nc1ccc(cc1)C(N)=O)c1cc(ccc1Cl)[N+]([O-])=O | InChi: | InChI=1S/C14H10ClN3O4/c15-12-6-5-10(18(21)22)7-11(12)14(20)17-9-3-1-8(2-4-9)13(16)19/h1-7H,(H2,16,19)(H,17,20) | Definition date: | 2022-12-15 | Last modified: | 2024-09-27 | Release date: | 2024-03-20 | Identifier: | N-(4-carbamoylphenyl)-2-chloro-5-nitrobenzamide |
|
 | 4J6 | Name: | (4R,5S)-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-3-({(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | Formula: | C15 H26 N4 O6 S2 | SMILES: | CC(O)C(C=O)C2NC(C(O)=O)=C(SC1CNC(CNS(N)(=O)=O)C1)C2C | InChi: | InChI=1S/C15H26N4O6S2/c1-7-12(11(6-20)8(2)21)19-13(15(22)23)14(7)26-10-3-9(17-5-10)4-18-27(16,24)25/h6-12,17-19,21H,3-5H2,1-2H3,(H,22,23)(H2,16,24,25)/t7-,8-,9+,10+,11-,12-/m1/s1 | Synonyms: | Doripenem(open form, pyrroline tautomer form 1, SP2 connection to Thio) | Definition date: | 2015-11-18 | Last modified: | 2024-09-27 | Release date: | 2015-11-25 | Identifier: | (4R,5S)-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-3-({(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid |
|
 | RVJ | Name: | 3-triazan-1-yl-L-alanine | Formula: | C3 H10 N4 O2 | SMILES: | NC(CNNN)C(=O)O | InChi: | InChI=1S/C3H10N4O2/c4-2(3(8)9)1-6-7-5/h2,6-7H,1,4-5H2,(H,8,9)/t2-/m0/s1 | Definition date: | 2020-02-26 | Last modified: | 2024-09-27 | Release date: | 2020-07-01 | Identifier: | 3-triazan-1-yl-L-alanine |
|
 | KKR | Name: | 1-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-6-methyl-hept-5-ene-1,4-
dione | Formula: | C30 H35 N7 O3 S | SMILES: | O=C(C=C(/C)C)CCC(=O)N1CCN(CC1)Cc3sc2c(nc(nc2c3)c5cccc4nncc45)N6CCOCC6 | InChi: | InChI=1S/C30H35N7O3S/c1-20(2)16-21(38)6-7-27(39)36-10-8-35(9-11-36)19-22-17-26-28(41-22)30(37-12-14-40-15-13-37)33-29(32-26)23-4-3-5-25-24(23)18-31-34-25/h3-5,16-18H,6-15,19H2,1-2H3,(H,31,34) | Synonyms: | 1-[4-[[2-(1H-indazol-4-yl)-4-morpholinthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-6-methyl-hept-5-ene-1,4-dione | Definition date: | 2013-01-09 | Last modified: | 2024-09-27 | Release date: | 2013-02-08 | Identifier: | 1-(4-{[2-(1H-indazol-4-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazin-1-yl)-6-methylhept-5-ene-1,4-dione |
|
 | NEN | Name: | 1-ETHYL-PYRROLIDINE-2,5-DIONE | Formula: | C6 H9 N O2 | SMILES: | O=C1N(C(=O)CC1)CC | InChi: | InChI=1S/C6H9NO2/c1-2-7-5(8)3-4-6(7)9/h2-4H2,1H3 | Definition date: | 1999-08-17 | Last modified: | 2024-09-27 | Identifier: | 1-ethylpyrrolidine-2,5-dione |
|
 | NSN | Name: | N~2~-(2-AMINO-1-METHYL-2-OXOETHYLIDENE)ASPARAGINATE | Formula: | C7 H11 N3 O4 | SMILES: | [O-]C(=O)CC(/[NH+]=C(/C(=O)N)C)C(=O)N | InChi: | InChI=1S/C7H11N3O4/c1-3(6(8)13)10-4(7(9)14)2-5(11)12/h4H,2H2,1H3,(H2,8,13)(H2,9,14)(H,11,12)/b10-3+/t4-/m0/s1 | Definition date: | 2003-07-07 | Last modified: | 2024-09-27 | Identifier: | (3S)-4-amino-3-{[(1E)-2-amino-1-methyl-2-oxoethylidene]ammonio}-4-oxobutanoate |
|
 | PVA | Name: | 1-AMINO-2-METHYL-PROPYLPHOSPHONIC ACID | Formula: | C4 H12 N O3 P | SMILES: | O=P(O)(O)C(N)C(C)C | InChi: | InChI=1S/C4H12NO3P/c1-3(2)4(5)9(6,7)8/h3-4H,5H2,1-2H3,(H2,6,7,8)/t4-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(1R)-1-amino-2-methylpropyl]phosphonic acid |
|
 | V2X | Name: | (1~{S},2~{S})-~{N}'-ethanoyl-2-(3-methylphenyl)cyclopropane-1-carbohydrazide | Formula: | C13 H16 N2 O2 | SMILES: | CC(=O)NNC(=O)[CH]1C[CH]1c2cccc(C)c2 | InChi: | InChI=1S/C13H16N2O2/c1-8-4-3-5-10(6-8)11-7-12(11)13(17)15-14-9(2)16/h3-6,11-12H,7H2,1-2H3,(H,14,16)(H,15,17)/t11-,12+/m1/s1 | Definition date: | 2023-02-21 | Last modified: | 2024-09-27 | Release date: | 2023-11-15 | Identifier: | (1~{S},2~{S})-~{N}'-ethanoyl-2-(3-methylphenyl)cyclopropane-1-carbohydrazide |
|
 | ZAB | Name: | (3-{(Z)-[3-(AMINOMETHYL)PHENYL]DIAZENYL}PHENYL)ACETIC ACID | Formula: | C15 H15 N3 O2 | SMILES: | O=C(O)Cc2cccc(N=N/c1cccc(c1)CN)c2 | InChi: | InChI=1S/C15H15N3O2/c16-10-12-4-2-6-14(8-12)18-17-13-5-1-3-11(7-13)9-15(19)20/h1-8H,9-10,16H2,(H,19,20)/b18-17- | Definition date: | 2006-06-01 | Last modified: | 2024-09-27 | Identifier: | (3-{(Z)-[3-(aminomethyl)phenyl]diazenyl}phenyl)acetic acid |
|
 | RH5 | Name: | 4-[(3~{R})-1-oxidanyl-3,4-dihydro-2,1-benzoxaborinin-3-yl]-2-(pyridin-3-ylmethoxy)benzenecarboximidamide | Formula: | C21 H20 B N3 O3 | SMILES: | NC(=N)c1ccc(cc1OCc2cccnc2)[CH]3Cc4ccccc4B(O)O3 | InChi: | InChI=1S/C21H20BN3O3/c23-21(24)17-8-7-16(11-20(17)27-13-14-4-3-9-25-12-14)19-10-15-5-1-2-6-18(15)22(26)28-19/h1-9,11-12,19,26H,10,13H2,(H3,23,24)/t19-/m1/s1 | Definition date: | 2019-08-16 | Last modified: | 2024-09-27 | Release date: | 2019-09-25 | Identifier: | 4-[(3~{R})-1-oxidanyl-3,4-dihydro-2,1-benzoxaborinin-3-yl]-2-(pyridin-3-ylmethoxy)benzenecarboximidamide |
|
 | NEP | Name: | N1-PHOSPHONOHISTIDINE | Formula: | C6 H10 N3 O5 P | SMILES: | O=P(O)(O)n1cc(nc1)CC(C(=O)O)N | InChi: | InChI=1S/C6H10N3O5P/c7-5(6(10)11)1-4-2-9(3-8-4)15(12,13)14/h2-3,5H,1,7H2,(H,10,11)(H2,12,13,14)/t5-/m0/s1 | Definition date: | 1999-07-26 | Last modified: | 2024-09-27 | Identifier: | 1-phosphono-L-histidine |
|
 | A1ALE | Name: | (2S)-2-amino-7-(dimethylamino)-7-oxoheptanoic acid | Formula: | C9 H18 N2 O3 | SMILES: | NC(CCCCC(=O)N(C)C)C(=O)O | InChi: | InChI=1S/C9H18N2O3/c1-11(2)8(12)6-4-3-5-7(10)9(13)14/h7H,3-6,10H2,1-2H3,(H,13,14)/t7-/m0/s1 | Definition date: | 2024-04-08 | Last modified: | 2024-09-27 | Release date: | 2024-07-03 | Identifier: | (2S)-2-amino-7-(dimethylamino)-7-oxoheptanoic acid |
|
 | NSO | Name: | ~{N}-[3-[[6-fluoranyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide | Formula: | C28 H28 F N7 O | SMILES: | CN1CCN(CC1)c2ccc(Nc3nc(Nc4cccc(NC(=O)C=C)c4)c5cc(F)ccc5n3)cc2 | InChi: | InChI=1S/C28H28FN7O/c1-3-26(37)30-21-5-4-6-22(18-21)31-27-24-17-19(29)7-12-25(24)33-28(34-27)32-20-8-10-23(11-9-20)36-15-13-35(2)14-16-36/h3-12,17-18H,1,13-16H2,2H3,(H,30,37)(H2,31,32,33,34) | Definition date: | 2023-01-18 | Last modified: | 2024-09-27 | Release date: | 2023-08-23 | Identifier: | ~{N}-[3-[[6-fluoranyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide |
|
 | XZP | Name: | (1R,2R)-2-aminocyclopentane-1-carboxylic acid | Formula: | C6 H11 N O2 | SMILES: | O=C(C1CCCC1N)O | InChi: | InChI=1S/C6H11NO2/c7-5-3-1-2-4(5)6(8)9/h4-5H,1-3,7H2,(H,8,9)/t4-,5-/m1/s1 | Definition date: | 2017-05-18 | Last modified: | 2024-09-27 | Release date: | 2018-02-21 | Identifier: | (1R,2R)-2-aminocyclopentane-1-carboxylic acid |
|
 | RH6 | Name: | (2E)-3-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]prop-2-enal, bound form | Formula: | C16 H19 N O2 | SMILES: | CCN(CC)c1ccc2C=C(C=CC)C(=O)Oc2c1 | InChi: | InChI=1S/C16H19NO2/c1-4-7-13-10-12-8-9-14(17(5-2)6-3)11-15(12)19-16(13)18/h4,7-11H,5-6H2,1-3H3/b7-4+ | Definition date: | 2022-06-23 | Last modified: | 2024-09-27 | Release date: | 2023-02-01 | Identifier: | 7-(diethylamino)-3-[(1E)-prop-1-en-1-yl]-2H-1-benzopyran-2-one |
|
 | NEQ | Name: | N-ETHYLMALEIMIDE | Formula: | C6 H7 N O2 | SMILES: | O=C1C=CC(=O)N1CC | InChi: | InChI=1S/C6H7NO2/c1-2-7-5(8)3-4-6(7)9/h3-4H,2H2,1H3 | Definition date: | 2000-11-28 | Last modified: | 2024-09-27 | Identifier: | 1-ethyl-1H-pyrrole-2,5-dione |
|
 | ZAE | Name: | N-methyl-D-phenylalanine | Formula: | C10 H13 N O2 | SMILES: | O=C(O)C(NC)Cc1ccccc1 | InChi: | InChI=1S/C10H13NO2/c1-11-9(10(12)13)7-8-5-3-2-4-6-8/h2-6,9,11H,7H2,1H3,(H,12,13)/t9-/m1/s1 | Definition date: | 2009-02-06 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-phenylalanine |
|
 | VXA | Name: | METHYLPHOSPHONIC ACID ESTER GROUP | Formula: | C H4 O2 P | SMILES: | [O-]P(=O)C | InChi: | InChI=1S/CH5O2P/c1-4(2)3/h4H,1H3,(H,2,3)/p-1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | methylphosphinate |
|
 | T3R | Name: | N,5-dimethyl-L-norleucine | Formula: | C8 H17 N O2 | SMILES: | CNC(CCC(C)C)C(=O)O | InChi: | InChI=1S/C8H17NO2/c1-6(2)4-5-7(9-3)8(10)11/h6-7,9H,4-5H2,1-3H3,(H,10,11)/t7-/m0/s1 | Definition date: | 2022-07-15 | Last modified: | 2024-09-27 | Release date: | 2023-05-24 | Identifier: | N,5-dimethyl-L-norleucine |
|
 | PVE | Name: | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]-8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2-A]QUINOLIN-11-IUM | Formula: | C17 H18 N3 O7 | SMILES: | O=C(O)CCC(=O)Nc1cc3c([n+]2c1NCCC2C(=O)O)cc(O)c(O)c3 | InChi: | InChI=1S/C17H17N3O7/c21-12-6-8-5-9(19-14(23)1-2-15(24)25)16-18-4-3-10(17(26)27)20(16)11(8)7-13(12)22/h5-7,10H,1-4H2,(H5,18,19,21,22,23,24,25,26,27)/p+1/t10-/m0/s1 | Definition date: | 2008-10-14 | Last modified: | 2024-09-27 | Identifier: | (1S)-1-carboxy-5-[(3-carboxypropanoyl)amino]-8,9-dihydroxy-1,2,3,4-tetrahydropyrimido[1,2-a]quinolin-11-ium |
|
 | QPA | Name: | S-[(1S)-1-carboxy-1-(phosphonooxy)ethyl]-L-cysteine | Formula: | C6 H12 N O8 P S | SMILES: | O=C(O)C(OP(=O)(O)O)(SCC(C(=O)O)N)C | InChi: | InChI=1S/C6H12NO8PS/c1-6(5(10)11,15-16(12,13)14)17-2-3(7)4(8)9/h3H,2,7H2,1H3,(H,8,9)(H,10,11)(H2,12,13,14)/t3-,6-/m0/s1 | Definition date: | 2011-07-12 | Last modified: | 2024-09-27 | Identifier: | S-[(1S)-1-carboxy-1-(phosphonooxy)ethyl]-L-cysteine |
|
 | ZT1 | Name: | N~6~-[(1-methyl-1H-imidazol-5-yl)methyl]-N~6~-propan-2-yl-L-lysine | Formula: | C14 H26 N4 O2 | SMILES: | Cn1cncc1CN(CCCCC(N)C(=O)O)C(C)C | InChi: | InChI=1S/C14H26N4O2/c1-11(2)18(9-12-8-16-10-17(12)3)7-5-4-6-13(15)14(19)20/h8,10-11,13H,4-7,9,15H2,1-3H3,(H,19,20)/t13-/m0/s1 | Definition date: | 2021-05-28 | Last modified: | 2024-09-27 | Release date: | 2021-07-21 | Identifier: | N~6~-[(1-methyl-1H-imidazol-5-yl)methyl]-N~6~-propan-2-yl-L-lysine |
|
 | SAL | Name: | 2-HYDROXYBENZOIC ACID | Formula: | C7 H6 O3 | SMILES: | O=C(O)c1ccccc1O | InChi: | InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10) | Synonyms: | SALICYLIC ACID | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2-hydroxybenzoic acid |
|
 | V32 | Name: | 4-morpholin-4-ylcarbonylbenzaldehyde | Formula: | C12 H13 N O3 | SMILES: | O=Cc1ccc(cc1)C(=O)N2CCOCC2 | InChi: | InChI=1S/C12H13NO3/c14-9-10-1-3-11(4-2-10)12(15)13-5-7-16-8-6-13/h1-4,9H,5-8H2 | Definition date: | 2021-04-08 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-morpholin-4-ylcarbonylbenzaldehyde |
|